Dmp1 Inhibitors
Dmp1 inhibitors as a chemical class represent a diverse group of compounds that indirectly affect the function of Dentin Matrix Protein 1 by modulating various signaling pathways implicated in bone and dentin formation and maintenance. These inhibitors do not target the Dmp1 protein directly but instead interfere with upstream or downstream elements that control its expression or activity. The chemical inhibitors listed primarily focus on disrupting the BMP, TGF-β, and Wnt/β-catenin signaling pathways. These pathways are known to play critical roles in osteoblast differentiation, bone formation, and repair, which are processes where Dmp1 is a significant factor.
The inhibition of these signaling cascades can be achieved through various mechanisms, such as the binding to ligands (e.g., Noggin), inhibition of receptor kinases (e.g., LDN-193189 and SB-431542), stabilization of pathway inhibitors (e.g., XAV-939), or blocking protein-protein interactions (e.g., ICG-001 and PRI-724). By influencing these pathways, the activity of Dmp1 in bone and dentin mineralization may be indirectly regulated. Despite the diversity in their structures and target specificities, these chemicals share the common feature of modulating cellular signaling that could govern the functional outcomes associated with Dmp1, which include the mineralization of the extracellular matrix and the regulation of osteogenic differentiation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Also called LDN-193189, this compound is a small molecule that inhibits BMP type I receptor kinases ALK2 and ALK3, which can affect downstream signaling involving Dmp1. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 selectively inhibits the kinase activity of TGF-β type I receptors ALK4, ALK5, and ALK7, which could alter the regulatory effects on Dmp1 activity associated with TGF-β signaling. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275 inhibits AMPK and several BMP receptors, disrupting BMP signaling and potentially affecting Dmp1's involvement in bone and dentin mineralization processes. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 inhibits the production of Wnt proteins, thereby potentially decreasing β-catenin signaling and influencing the pathways that could regulate Dmp1's activity in osteogenesis. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 stabilizes axin by inhibiting tankyrase, which leads to the degradation of β-catenin and may indirectly impact signaling pathways regulating Dmp1. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW 55 inhibits the production of active β-catenin by inhibiting the enzyme responsible for its production, potentially impacting pathways that regulate Dmp1. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 promotes the degradation of β-catenin, potentially affecting the Wnt/β-catenin pathway and thus indirectly Dmp1-related signaling. | ||||||
PNU-74654 | 113906-27-7 | sc-258020 sc-258020A | 5 mg 25 mg | $131.00 $495.00 | 7 | |
PNU-74654 disrupts Wnt signaling by binding to β-catenin, preventing its interaction with TCF/LEF transcription factors, which can have downstream effects on Dmp1-related activities. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535 inhibits both Wnt/β-catenin and PPAR signaling pathways, potentially influencing the cellular activities associated with Dmp1. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
PRI-724 disrupts the interaction between β-catenin and CBP, which may alter Wnt signaling and indirectly influence Dmp1's role in the regulation of bone and dentin mineralization. | ||||||